Abstract CT036: A first-in-human study result of a novel EGFR-targeted antibody drug conjugate (ADC) in patients with advanced nasopharyngeal carcinoma (NPC) (SYS6010-001-NPC)
Year: 2026
Type: conference-abstract
Source: Cancer Research
Institutions: Sun Yat-sen University, Sun Yat-sen University Cancer Center, First Affiliated Hospital of Guangdong Pharmaceutical University, Fujian Provincial Cancer Hospital, Sichuan University, West China Hospital of Sichuan University, Kunming Medical University, Guangxi Medical University, Tumor Hospital of Guangxi Medical University, Huazhong University of Science and Technology, Chongqing University, Chongqing Cancer Hospital, Hunan Cancer Hospital, Affiliated Hospital of Hebei University, Hebei University, Hainan Medical University, Army Medical University, Daping Hospital, CSPC Pharmaceutical Group, Shanghai Chest Hospital
Language: English
Topic: Head and Neck Cancer Studies
Subfield: Otorhinolaryngology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7154746779
Cites:
Cited by:
Related to: